Epidemiology and Care Strategies for Dementia in Older Adults

Summary

The global burden of dementia is rising in parallel with demographic ageing, with over 55 million individuals currently affected and projections exceeding 150 million by 2050. Age remains the foremost risk factor, although sex, genetic predisposition and cardiovascular comorbidities also contribute significantly. Social determinants such as education, socioeconomic status and urban versus rural residence shape prevalence and incidence patterns, while regional differences reflect diverse lifestyle and healthcare access. Care strategies encompass pharmacological treatments targeting neurochemical pathways, but these offer only modest symptomatic relief. Non-pharmacological approaches—including cognitive stimulation, structured activities and physical exercise—have demonstrated benefits in quality of life and functional maintenance. Integrated care models that combine primary healthcare support, community-based services and caregiver education are emerging as best practice, emphasising early diagnosis, personalised care pathways and multidisciplinary teams. Digital tools for screening, remote monitoring and therapeutic engagement are increasingly deployed, offering scalable solutions in resource-constrained environments. Across settings, caregiver burden remains high, prompting policy initiatives to strengthen support networks, respite care and training programmes. Aligning epidemiological insights with innovative care frameworks is critical to mitigate the personal, societal and economic impacts of dementia among older adults.

Research from Nature Portfolio

Recent studies have refined our understanding of global dementia patterns by integrating data from over 120 countries and applying advanced modelling to estimate age-specific incidence and projections through 2050. This work highlights both the deceleration of age-standardised rates in high-income regions and rising prevalence in low- and middle-income countries, underscoring the need for tailored public health responses. Another investigation has validated a panel of blood-based biomarkers that predict cognitive decline up to five years before clinical onset, offering promise for early intervention trials. Meanwhile, research into digital therapeutics has demonstrated that home-based cognitive training delivered via smartphone applications can slow deterioration in executive function and memory in individuals with mild cognitive impairment, paving the way for scalable, non-invasive care adjuncts.

Epidemiology and Care Strategies for Dementia in Older Adults publication trend

The graph below shows the total number of articles in epidemiology and care strategies for dementia in older adults across all publications each year (not limited to Nature Index journals).

Technical terms

Prevalence: The proportion of a population affected by dementia at a given point in time.

Incidence: The rate at which new cases of dementia occur in a defined population over a specified period.

Mild cognitive impairment (MCI): A clinical state characterised by measurable cognitive decline beyond normal ageing but not severe enough to interfere substantially with daily life.

Activities of daily living (ADL): Routine tasks such as bathing, dressing and eating, used to assess functional independence in older adults.

Non-pharmacological intervention: Therapeutic approaches that do not involve medication, including cognitive training, exercise and behavioural therapies.

Caregiver burden: The physical, emotional and financial strain experienced by individuals who provide informal care to persons with dementia.

References

  1. The prevalence and risk factors study of cognitive impairment: Analysis of the elderly population of Han nationality in Hunan province, China. CNS Neuroscience & Therapeutics (2023).
  2. Prevalence of dementia in mainland China, Hong Kong and Taiwan: an updated systematic review and meta-analysis. International Journal of Epidemiology (2018).
  3. The economic burden of dementia in China, 1990–2030: implications for health policy. Bulletin of the World Health Organization (2016).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.